C12N 2770/32341
Use of virus, viral particle or viral elements as a vector
C12N2770/32341 (Use of virus, viral particle or viral elements as a vector) appears on 14 US grants and 22 published applications in this corpus.
Search patents in C12N- Granted patents
- 14
- Published applications
- 22
- Assignees
- 25
- Inventors
- 75
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 2 |
| 2020 | 1 | 3 |
| 2021 | 0 | 1 |
| 2022 | 1 | 4 |
| 2023 | 2 | 2 |
| 2024 | 0 | 3 |
| 2025 | 3 | 4 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2770/32343Viral genome or elements thereof as genetic vectorIndexing code13
- C12N 2770/32344Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code1
- C12N 2770/32342Virus or viral particle as vehicleIndexing code0
- C12N 2770/32345Special targeting system for viral vectorsIndexing code0
Recent patents
- Constructs and methods for preparing circular RNA23 Jun 2026US 12,662,671 B2Peking University
- Antitumor virus30 Dec 2025US 12,508,291 B2Shanxi Academy of Advanced Research and Innovation
- Pharmaceutical composition containing stabilized nucleic acid adjuvant11 Nov 2025US 12,465,644 B2Sml Biopharm Co., Ltd.
- Viral vector delivery system for both respiratory and digestive tracts of pigs and application thereof26 Aug 2025US 12,397,049 B2Guotai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou
- Virus for treatment of tumor24 Oct 2023US 11,793,844 B2Xiamen University
- Genetically modified enterovirus vectors with enhanced genomic stability2 Oct 2025US 2025/0304999 A1Virogin Biotech Canada Ltd
- Using infectious nucleic acid to treat cancer7 Aug 2025US 2025/0249053 A1Mayo Foundation for Medical Education and Research
- Parasporin expression vector and pharmaceutical composition10 Jul 2025US 2025/0223322 A1N.P.T. S.R.L.
- Viral vector delivery system for both respiratory and digestive tracts of pigs and application thereof1 May 2025US 2025/0134983 A1Guotai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou
- Modified piv5 vaccine vectors: methods of making and uses29 Aug 2024US 2024/0287544 A1Cyanvac LLC
Most cited
By later US patents
- Coxsackie virus as a vector for delivery of anti-inflammatory cytokines16US 6,071,742 ABoard of Regents of the University of Nebraska · 2000
- Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products6US 6,323,024 B1Board of Regents of the University of Nebraska · 2001
- Gene-modified coxsackievirus1US 10,076,547 B2Kyushu University, National University Corporation · 2018